These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34733371)

  • 1. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
    Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
    Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells.
    E Z; Li C; Xiang Y
    Open Med (Wars); 2020; 15(1):1193-1201. PubMed ID: 33336076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
    Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J
    J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXD3-AS1 Knockdown Suppresses Hypoxia-Induced Cardiomyocyte Injury by Increasing Cell Survival and Inhibiting Apoptosis
    Zheng J; Peng B; Zhang Y; Ai F; Hu X
    Front Pharmacol; 2020; 11():1284. PubMed ID: 32973515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
    Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
    Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
    Ma WG; Shi SM; Chen L; Lou G; Feng XL
    J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wan N; Yang W; Cheng H; Wang J
    Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
    Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G
    Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis.
    Qi G; Li L
    Onco Targets Ther; 2020; 13():6361-6371. PubMed ID: 32669856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA AGAP2-AS1/miR-628-5p/PTN Axis Modulates Proliferation, Migration, Invasion, and Apoptosis of Glioma Cells.
    Yan Y; Wang Y; Liu Y; Chen T; Zhu Y; Li H; Kong F
    Cancer Manag Res; 2020; 12():6059-6068. PubMed ID: 32801858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZIN1-AS1, A Novel Oncogenic LncRNA, Promotes the Progression of Non-Small Cell Lung Cancer by Regulating MiR-513b-5p and DUSP11.
    Cai Y; Wu Q; Liu Y; Wang J
    Onco Targets Ther; 2020; 13():9667-9678. PubMed ID: 33116570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR.
    Liu C; Zhang M; Zhao J; Zhu X; Zhu L; Yan M; Zhang X; Zhang R
    Cancer Biother Radiopharm; 2020 May; 35(4):292-300. PubMed ID: 32191537
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
    Huang N; Guo W; Ren K; Li W; Jiang Y; Sun J; Dai W; Zhao W
    Front Oncol; 2019; 9():1103. PubMed ID: 31696057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.